Rein Therapeutics's total assets for Q2 2026 were $65.97M, an increase of 173.09% from the previous quarter. DE:015A total liabilities were $55.77M for the fiscal quarter, a 670.36% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.